Envestnet Portfolio Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.33M Buy
179,745
+24,744
+16% +$647K 0.02% 351
2026
Q1
$4.35M Sell
155,001
-88,650
-36% -$2.36M 0.02% 310
2025
Q4
$6.07M Buy
243,651
+378
+0.2% +$9.53K 0.02% 327
2025
Q3
$6.2M Sell
243,273
-3,441
-1% -$84.9K 0.02% 308
2025
Q2
$5.98M Sell
246,714
-100,429
-29% -$2.34M 0.02% 319
2025
Q1
$8.8M Sell
347,143
-253,223
-42% -$6.63M 0.03% 251
2024
Q4
$15.9M Buy
600,366
+20,991
+4% +$569K 0.05% 168
2024
Q3
$16.8M Buy
579,375
+4,041
+0.7% +$118K 0.05% 171
2024
Q2
$16.1M Buy
575,334
+21,167
+4% +$583K 0.06% 171
2024
Q1
$15.4M Buy
554,167
+115,725
+26% +$3.21M 0.06% 170
2023
Q4
$12.6M Sell
438,442
-10,359
-2% -$313K 0.05% 181
2023
Q3
$14.9M Buy
+448,801
New +$15.9M 0.07% 140

Other funds holding PFE

Envestnet Portfolio Solutions's PFE Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Pfizer (PFE) stake by 16% in Q2 2026, buying an estimated $647K and bringing the position to 179,745 shares worth $4.33M. The position accounts for 0.02% of the portfolio, ranked #351.

Envestnet Portfolio Solutions first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $16.8M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Envestnet Portfolio Solutions held 179,745 shares of Pfizer worth $4.33M as of Q2 2026.
  • Envestnet Portfolio Solutions bought 24,744 Pfizer shares in Q2 2026, an estimated $647K.
  • Pfizer made up 0.02% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #351 holding.
  • Envestnet Portfolio Solutions first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Pfizer position peaked at $16.8M in Q3 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.